| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Outlook
Our guidance for 2024 is unchanged, with the exception of adjusted EBITDA margin. Adjusted EBITDA margin guidance has increased from a range of 9.0% to 11.0% to a range of 9.5% to 11.5% after giving consideration for the exclusion of stock based compensation expense in our adjusted EBITDA margin.
Revenue in the range of $3.8 billion to $4.0 billion
Adjusted EBITDA margin in the range of 9.5% to 11.5%
SG&A expense in the range of 7.5% to 8.0% of revenue
Mid-20s effective tax rate for adjusted net income
Capital expenditures of approximately $130 million to $150 million
Posted In: GVA
